USPTO serial 90902074
PSILOTHERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- FOSTER, ALEXANDRA M.
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PSILOTHERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenneth L. Sherman
KENNETH L. SHERMAN SHERMAN IP LLP1519 26TH STREETSANTA MONICA, CA 90404UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific study and research in the field of psilocybins for the treatment of mental health; psychological research; testing, inspection, research, or development of psilocybin preparations for mental health treatment; research and development of psilocybin preparations for the treatment of mental health; clinical research in the field of psilocybins for the treatment of mental health; medical and scientific research in the field of mental health treatment and diagnosis; online non-downloadable web platform for use in connection with healthcare; design and development of computer software, in particular for medical care; scientific and technological services and research and design relating thereto, in the fields of treatment monitoring, treatment effectiveness, patient communication and the use of information technologies in particular for the medical sector; computer software design, development and implementation of software in the healthcare industry; computer software design, development and implementation of software to improve healthcare communication and healthcare workflow; computer software design, development and implementation of software for telemedicine and telehealth; platform as a service (PAAS) featuring computer software platforms for remote healthcare monitoring, and administering and monitoring telemedicine and telehealth services; software as a service (SAAS) services, namely, hosting software for use by others for remote healthcare monitoring, and administering and monitoring telemedicine and telehealth services; software as a service (SAAS) services featuring healthcare professional practice management software; software as a service (SAAS) services featuring scheduling software, patient profiling information software, electronic prescriptions software, electronic healthcare records software and electronic medical records software; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in connection with psilocybin treatments for mental health; providing temporary use of on-line nondownloadable software and applications for scheduling healthcare appointments, obtaining mobile medical services, telemedicine services, providing information about healthcare services, and providing information about healthcare providers; providing a web site featuring nondownloadable software for providing telehealth, telemedicine, remote care, and virtual health care services to patients; providing temporary use of non-downloadable software for patients and healthcare providers to use in collaborating, monitoring, managing, tracking, and communicating concerning health care, wellness, and mental health treatment and management | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 18, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 18, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 5, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2021 | NWAP | NEW APPLICATION ENTERED | — |